Holder, this was a non-event to me. Did you really expect an approval? I made the odds 80-20 against. The key was it wasn't a flat denial. There is still hope and I truly believe Agenda is the real deal here, Tesetaxel has much promise, and I will be a big buyer coming Monday if it drops to my buying point. We shall see. Again, I don't believe for 1 second people have been buying this stock for CLL after FDA denied them twice already. It makes no sense. Its the Agenda trial and now Tesetaxel that has attracted this new group of buyers. You will see.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.